Costs of running a universal adolescent hepatitis B vaccination programme

被引:22
作者
Wallace, LA
Young, D
Brown, A
Cameron, JC
Ahmed, S
Duff, R
Carman, WF
Kitchin, NRE
Nguyen-Van-Tam, JS
Goldberg, DJ
机构
[1] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
[2] Greater Glasgow NHS Board, Glasgow G3 8YU, Lanark, Scotland
[3] Sch Hlth Serv, Yorkhill NHS Trust, Glasgow G5 0RE, Lanark, Scotland
[4] Gartnavel Royal Hosp, Specialist Virol Ctr, Glasgow G12 0ZA, Lanark, Scotland
[5] Sanofi Pasteur MSD, Maidenhead SL6 1QP, Berks, England
[6] Hlth Protect Agcy, Ctr Infect, London NW9 5DE, England
关键词
cost analysis; hepatitis B vaccine; adolescent programme;
D O I
10.1016/j.vaccine.2005.06.034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the first UK study to examine feasibility and acceptability of universal adolescent hepatitis B vaccination, the costs associated with the administration and uptake (80.2 and 89.3% for three doses and at least two doses. respectively). of a three-dose regimen in pupils in Glasgow schools (2001/2002) were measured. These data were used to estimate the economic outlay for the delivery of a routine ongoing three-dose and two-dose hepatitis B vaccine programme in schools. Vaccine, accounting for almost 70% of the overall costs was the largest cost item for both the pilot and routine programmes, using either regimen. However. the ongoing, two-dose regimen was the cheapest option in this analysis, irrespective of vaccine price. Cost data from this study may be useful for other countries wishing to implement a similar programme, (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5624 / 5631
页数:8
相关论文
共 15 条
[1]  
Bramley J C, 2002, Commun Dis Public Health, V5, P318
[2]   A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: Antibody responses, safety, and immunologic memory [J].
Cassidy, WM ;
Watson, B ;
Ioli, VA ;
Williams, K ;
Bird, S ;
West, DJ .
PEDIATRICS, 2001, 107 (04) :626-631
[3]   The Denver school-based adolescent hepatitis B vaccination program: A cost analysis with risk simulation [J].
Deuson, RR ;
Hoektra, EJ ;
Sedjo, R ;
Bakker, G ;
Melinkovich, P ;
Daeke, D ;
Hammer, AL ;
Goldsman, D ;
Judson, FN .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (11) :1722-1727
[4]   ASSESSMENT OF A UNIVERSAL, SCHOOL-BASED HEPATITIS-B VACCINATION PROGRAM [J].
DOBSON, S ;
SCHEIFELE, D ;
BELL, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15) :1209-1213
[5]  
Edmunds W J, 1998, Commun Dis Public Health, V1, P221
[6]   An economic evaluation of universal vaccination against hepatitis B virus [J].
Fenn, P ;
Gray, A ;
McGuire, A .
JOURNAL OF INFECTION, 1996, 32 (03) :197-204
[7]   Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildren [J].
Guay, M ;
Clouâtre, AM ;
Blackburn, M ;
Baron, G ;
De Wals, P ;
Roy, C ;
Desrochers, J ;
Milord, F .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2003, 94 (01) :64-67
[8]   Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program [J].
Krahn, M ;
Guasparini, R ;
Sherman, M ;
Detsky, AS .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (11) :1638-1644
[9]  
MANTAGNI P, 1995, J EPIDEMIOL COMMUNIT, V49, P238
[10]   PREVENTION OF HEPATITIS-B VIRUS TRANSMISSION BY IMMUNIZATION - AN ECONOMIC-ANALYSIS OF CURRENT RECOMMENDATIONS [J].
MARGOLIS, HS ;
COLEMAN, PJ ;
BROWN, RE ;
MAST, EE ;
SHEINGOLD, SH ;
AREVALO, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15) :1201-1208